Skip to main content
. 2021 May 10;9(5):e001942. doi: 10.1136/jitc-2020-001942

Figure 4.

Figure 4

Effect of the copy number variation (CNV) risk score on overall survival after combination therapy of programmed cell death protein 1 (PD-1) inhibitor with lenvatinib, by clinical characteristics. Forest plot for overall survival in subgroups. Estimates are based on a Cox proportional hazards model. AFP, alpha-fetoprotein; ECOG, Eastern Cooperative Oncology Group; PD-L1, programmed death-ligand 1; TBS, tumor burden score; TNM, tumor, node, metastases.